Dicke K A, Spitzer G, Scheffers P H, Cork A, Ahearn M J, Löwenberg B, McCredie K B
Hamatol Bluttransfus. 1976;19:63-77. doi: 10.1007/978-3-642-87524-3_7.
Colony formation in vitro by marrow cells from patients with untreated acute myelogenous leukemia (AML) and from patients in AML relapse is infrequent using the standard Robinson assay. A newly developed culture system has been described in which marrow from AML patients in these disease stages form leukemic cell colonies. In this in vitro system, phytohaemagglutinin is the essential stimulator for colony formation. The leukemic origin of the colonies has been proven by ultrastructural morphology and cytogenetics. It appears that colony formation by leukemic cells in this system is predominantly independent from the leukocyte factor which is the main stimulator in the Robinson assay for growing colonies of marrow cells from haematologically normal individuals. Bone marrow cells in untreated acute myelogenous leukemia (AML) demonstrate abnormal growth in vitro in the Robinson assay (Robinson et al., 1971; and Bull et al., 1973). Characteristically, there is a near total failure of colony formation; predominantly clusters are formed containing 20 cells or less (Bull et al., 1973; Greenberg et al., 1971; Moore et al., 1973 and 1974, and van Bekkum et al., in press). The absence of colonies has been shown to be due to a marked decrease of the normal myeloid precursor cell population in untreated AML. The small agregate formation of AML cells has been attributed to the suboptimal response of leukemic cells to the leukocyte stimulation factor. Because this poor proliferation in vitro might not represent the maximal in vitro and in vivo proliferation potential of the leukemic cells, we studied a number of modifications of the in vitro culture system. A number of factors were studied which may have some influence on cell proliferation in general, notably phytohaemagglutinin (PHA), which induces lymphocyte colonies in vitro (Rozenszajn et al., 1974), and endotoxin which has been demonstrated to increase the labelling index of leukemic cells in vivo (Golde et al.). In this paper an in vitro system is described in which marrow cells from untreated AML and AML in relapse were stimulated by phytohaemagglutinin (PHA) to form leukemic cell colonies in soft agar. These (similar) cells predominantly formed small aggregates (20 cells or less) in the presence of the normal leukocyte feeder layer alone. Moreover, in the course of the experiments, it appeared that by adding low concentrations of endotoxin to the cultures, the stimulating effect of PHA could be amplified.
使用标准的罗宾逊检测法,未经治疗的急性髓性白血病(AML)患者以及处于AML复发期患者的骨髓细胞在体外形成集落的情况并不常见。已描述了一种新开发的培养系统,在该系统中,处于这些疾病阶段的AML患者的骨髓可形成白血病细胞集落。在这个体外系统中,植物血凝素是集落形成的必需刺激物。集落的白血病起源已通过超微结构形态学和细胞遗传学得到证实。在该系统中,白血病细胞形成集落似乎主要独立于白细胞因子,而白细胞因子是罗宾逊检测法中用于培养血液学正常个体骨髓细胞集落的主要刺激物。未经治疗的急性髓性白血病(AML)患者的骨髓细胞在罗宾逊检测法中显示出体外异常生长(罗宾逊等人,1971年;布尔等人,1973年)。其特征是集落形成几乎完全失败;主要形成含有20个或更少细胞的簇(布尔等人,1973年;格林伯格等人,1971年;摩尔等人,1973年和1974年,以及范·贝库姆等人,即将发表)。已证明集落缺失是由于未经治疗的AML中正常髓系前体细胞数量显著减少所致。AML细胞形成小聚集体归因于白血病细胞对白细胞刺激因子的反应欠佳。由于这种体外增殖不良可能不代表白血病细胞在体外和体内的最大增殖潜力,我们研究了体外培养系统的一些改进方法。研究了一些可能总体上对细胞增殖有影响的因素,特别是植物血凝素(PHA),它可在体外诱导淋巴细胞集落(罗森扎恩等人,1974年),以及内毒素,已证明内毒素可增加体内白血病细胞的标记指数(戈尔德等人)。本文描述了一种体外系统,其中未经治疗的AML和复发期AML的骨髓细胞受到植物血凝素(PHA)刺激,在软琼脂中形成白血病细胞集落。这些(类似的)细胞在仅存在正常白细胞饲养层的情况下主要形成小聚集体(20个或更少细胞)。此外,在实验过程中发现,向培养物中添加低浓度的内毒素可增强PHA的刺激作用。